CLINICAL ROLE -
Chemotherapy-Induced Cognitive Decline Improves with Experimental Drug
A reduction in the release of serotonin and dopamine may cause chemotherapy-related cognitive decline.
Read More
Experimental Drug May Reduce 'Chemobrain' Effect
Cognitive decline in patients with cancer administered chemotherapy may be a result of increased levels of hydrogen peroxide in the brain.
Positive Emotions Suppress HIV Load, Reduce Antidepressant Use
Positivity interventions may influence health outcomes in people living with HIV.
Protective Role of Gene Overexpression in Inflammatory Bowel Disease
High levels of the Cd14 gene increases gut barrier integrity.
Trending News Today: Research Advances Treatment of Epilepsy, Autism
Top news of the day from across the health care landscape.
Prognostic Tool Could Reduce End Stage Renal Disease in Diabetes Patients
New biomarkers could accurately predict the risk of renal failure among patients with type 1 and type 2 diabetes.
Protective Mechanisms Prevent Heart Damage
Mitochondrial circuit prevents widespread damage to heart muscle.
Trending News Today: Revised Healthcare Reform Bill Gains Steam
Top news of the day from across the healthcare landscape.
High-Dose Chemotherapy Plus Vaccine Increases Survival in Glioblastoma
Unexpected survival gains observed in glioblastoma patients administered an investigational dendritic cell vaccine and temozolomide.
Monthly PCSK9 Inhibitor Injection Gets FDA Approval
Cholesterol-lowering drug approved in once-monthly 300 mg dosing option.
Brivaracetam Found Safe in Combination with Other Epilepsy Drugs
Brivaracetam was approved because it was effective reducing seizure frequency when combined with other agents.
Gender Differences in Smoking Cessation Medication Effectiveness
This article will highlight the available clinical evidence showing the role of biological differences in the effectiveness of smoking cessation pharmacotherapy.
FDA Approves Treatment for Rare Form of Batten Disease
The FDA has approved cerliponase alfa (Brineura, BioMarin Pharmaceutical) to slow loss of walking ability in symptomatic pediatric patients aged 3 years and older with a specific form of Batten disease
5 Interesting Medication Case Reports - Part 3
This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice.
Second Cancers Produce Poorer Survival Outcomes in Young Adults
The substantial adverse impact of second cancers may explain the lack of improvement in young adult survival compared with older adults.
Community Pharmacists Call on Congress for Legislative Support
Pharmacists gather on capitol hill to garner Congressional support for pharmacy- and patient-focused legislation.
Drug Rebates: Do Patients Really Benefit?
A large portion of patients may be paying for drugs based on list prices.
Injection Drug Use Frequency Related to Markers of Immune Activation in HIV
Efforts to reduce injection frequency can have positive health benefits with or without HIV infection, study suggests.
Cannabis-Based Treatments May Be Beneficial for Skin Diseases
Cannabinoids observed to reduce inflammation in various skin conditions.
Biosimilars Expected to Increase Demand for Biopharmaceutical Analyzers
Increased development of biosimilars will drive the need for analytical instrument analyzers, report finds.
Chronic Venous Insufficiency Skyrockets Among Medicare Patients
Medicare beneficiaries with chronic venous insufficiency nearly triples from 2005 to 2014.
EGFR Presence in Tumors Helps Promote Bowel Cancer, Poorer Survival Prognosis
Increased expression of EGFR-positive myeloid cells associated with tumor progression and reduced survival in bowel cancer.
Trending News Today: Insurance Cost-Sharing Subsidies Are Key Issue in Government Shutdown
Myocardial Infarction Survival Improves with Exercise
Moderate or high physical activity improved heart attack survival by 47%.
Trending News Today: Revised Healthcare Reform Plan Could Gain More Support from Conservative Legislators
Monoclonal Antibodies Herald New Era in Migraine Treatment
Monoclonal antibody drugs may soon be an effective preventative treatment for chronic migraines.
Study Bolsters Use of Asthma Drug in Young Patients
Inhaled combination of budesonide and formoterol shows promise treating asthma in children aged 6 to 12.
Erenumab Shows Promise Treating Migraines in Phase 3 Trial
Erenumab is a monoclonal antibody that inhibits a neuropeptide strongly believed to play a role in the pathology of migraines.
Does Annual Influenza Vaccination Change Response?
Annual influenza vaccination is prudent for people at high risk from complications and for people who live or work in places where people aggregate.
Deadly Druggists: Pharmacists and the Death Penalty
What is our duty to patients? Does this change if we believe they are abominable?
